MPM Bioventures 2018, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 102,837 shares at $27.00 ($2.8M) on 2021-10-07, disclosed to the SEC on 2021-10-12.
Scheduled sale ($2.8M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 1,149 | $31K | 1.1% |
| 2 | $27.01 | 2,032 | $55K | 2.0% |
| 3 | $27.01 | 2,032 | $55K | 2.0% |
| 4 | $27.24 | 48,812 | $1.3M | 47.5% |
| 5 | $27.24 | 48,812 | $1.3M | 47.5% |
| Total | $27.23 avg | 102,837 |
| $2.8M |
| 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| AKTS | BUY | 2026-01-14 | $20.0M | — | Filing → |